Global Oligonucleotide Therapeutics Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Oligonucleotide Therapeutics market size will reach 8,358.84 Million USD in 2025 and is projected to reach 11,081.36 Million USD by 2032, with a CAGR of 4.11% (2025-2032). Notably, the China Oligonucleotide Therapeutics market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Oligonucleotide therapeutics are a class of therapeutic agents that utilize short DNA or RNA molecules, typically consisting of 20-50 nucleotides, to modulate gene expression or target specific disease-causing molecules in the body. These therapeutics can be designed to selectively bind to messenger RNA (mRNA), microRNA (miRNA), or other nucleic acid targets, interfering with their function or promoting specific biological processes. Oligonucleotide therapeutics can act by various mechanisms, including downregulating gene expression through mRNA degradation or blocking translation, correcting abnormal splicing of mRNA, or selectively inhibiting specific proteins or enzymes involved in disease processes. This versatile class of therapeutics has shown promise in treating a wide range of diseases, including genetic disorders, viral infections, neurological disorders, and cancer. Oligonucleotide therapeutics are typically delivered to target tissues or cells through various delivery systems, such as lipid nanoparticles or conjugates. Their development is an active area of research and clinical investigation, with several oligonucleotide-based drugs already approved for clinical use and many more in development.
The major global suppliers of Oligonucleotide Therapeutics include Biogen, Sarepta Therapeutics, Bausch & Lomb, Jazz Pharmaceuticals, Alnylam Pharmaceuticals, Akcea Therapeutics, Dynavax Technologies, Kastle therapeutics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oligonucleotide Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Oligonucleotide Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oligonucleotide Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oligonucleotide Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Oligonucleotide Therapeutics Include:
Biogen
Sarepta Therapeutics
Bausch & Lomb
Jazz Pharmaceuticals
Alnylam Pharmaceuticals
Akcea Therapeutics
Dynavax Technologies
Kastle therapeutics
Oligonucleotide Therapeutics Product Segment Include:
Antisense Oligonucleotide
Aptamer
Others
Oligonucleotide Therapeutics Product Application Include:
Neuromuscular Diseases
ATTR
Hepatic VOD
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oligonucleotide Therapeutics Industry PESTEL Analysis
Chapter 3: Global Oligonucleotide Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global Oligonucleotide Therapeutics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Oligonucleotide Therapeutics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Oligonucleotide Therapeutics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oligonucleotide Therapeutics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Oligonucleotide Therapeutics market size will reach 8,358.84 Million USD in 2025 and is projected to reach 11,081.36 Million USD by 2032, with a CAGR of 4.11% (2025-2032). Notably, the China Oligonucleotide Therapeutics market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Oligonucleotide therapeutics are a class of therapeutic agents that utilize short DNA or RNA molecules, typically consisting of 20-50 nucleotides, to modulate gene expression or target specific disease-causing molecules in the body. These therapeutics can be designed to selectively bind to messenger RNA (mRNA), microRNA (miRNA), or other nucleic acid targets, interfering with their function or promoting specific biological processes. Oligonucleotide therapeutics can act by various mechanisms, including downregulating gene expression through mRNA degradation or blocking translation, correcting abnormal splicing of mRNA, or selectively inhibiting specific proteins or enzymes involved in disease processes. This versatile class of therapeutics has shown promise in treating a wide range of diseases, including genetic disorders, viral infections, neurological disorders, and cancer. Oligonucleotide therapeutics are typically delivered to target tissues or cells through various delivery systems, such as lipid nanoparticles or conjugates. Their development is an active area of research and clinical investigation, with several oligonucleotide-based drugs already approved for clinical use and many more in development.
The major global suppliers of Oligonucleotide Therapeutics include Biogen, Sarepta Therapeutics, Bausch & Lomb, Jazz Pharmaceuticals, Alnylam Pharmaceuticals, Akcea Therapeutics, Dynavax Technologies, Kastle therapeutics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oligonucleotide Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Oligonucleotide Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oligonucleotide Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oligonucleotide Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Oligonucleotide Therapeutics Include:
Biogen
Sarepta Therapeutics
Bausch & Lomb
Jazz Pharmaceuticals
Alnylam Pharmaceuticals
Akcea Therapeutics
Dynavax Technologies
Kastle therapeutics
Oligonucleotide Therapeutics Product Segment Include:
Antisense Oligonucleotide
Aptamer
Others
Oligonucleotide Therapeutics Product Application Include:
Neuromuscular Diseases
ATTR
Hepatic VOD
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oligonucleotide Therapeutics Industry PESTEL Analysis
Chapter 3: Global Oligonucleotide Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global Oligonucleotide Therapeutics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Oligonucleotide Therapeutics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Oligonucleotide Therapeutics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oligonucleotide Therapeutics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Oligonucleotide Therapeutics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Oligonucleotide Therapeutics Product by Type
- 1.2.1 Antisense Oligonucleotide
- 1.2.2 Aptamer
- 1.2.3 Others
- 1.3 Oligonucleotide Therapeutics Product by Application
- 1.3.1 Neuromuscular Diseases
- 1.3.2 ATTR
- 1.3.3 Hepatic VOD
- 1.3.4 Others
- 1.4 Global Oligonucleotide Therapeutics Market Size Analysis (2020-2032)
- 1.5 Oligonucleotide Therapeutics Market Development Status and Trends
- 1.5.1 Oligonucleotide Therapeutics Industry Development Status Analysis
- 1.5.2 Oligonucleotide Therapeutics Industry Development Trends Analysis
- 2 Oligonucleotide Therapeutics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Oligonucleotide Therapeutics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Oligonucleotide Therapeutics Market Analysis by Country
- 4.1 Global Oligonucleotide Therapeutics Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Oligonucleotide Therapeutics Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Oligonucleotide Therapeutics Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.5 China Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.6 France Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.14 India Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Oligonucleotide Therapeutics Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Oligonucleotide Therapeutics Market Revenue by Key Suppliers (2021-2025)
- 5.2 Oligonucleotide Therapeutics Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Oligonucleotide Therapeutics Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Oligonucleotide Therapeutics Market Analysis by Type
- 6.1 Global Oligonucleotide Therapeutics Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Oligonucleotide Therapeutics Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Biogen
- 7.1.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Biogen Oligonucleotide Therapeutics Product Portfolio
- 7.1.3 Biogen Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Sarepta Therapeutics
- 7.2.1 Sarepta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Sarepta Therapeutics Oligonucleotide Therapeutics Product Portfolio
- 7.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Bausch & Lomb
- 7.3.1 Bausch & Lomb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Bausch & Lomb Oligonucleotide Therapeutics Product Portfolio
- 7.3.3 Bausch & Lomb Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Jazz Pharmaceuticals
- 7.4.1 Jazz Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Jazz Pharmaceuticals Oligonucleotide Therapeutics Product Portfolio
- 7.4.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Alnylam Pharmaceuticals
- 7.5.1 Alnylam Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Product Portfolio
- 7.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Akcea Therapeutics
- 7.6.1 Akcea Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Akcea Therapeutics Oligonucleotide Therapeutics Product Portfolio
- 7.6.3 Akcea Therapeutics Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Dynavax Technologies
- 7.7.1 Dynavax Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Dynavax Technologies Oligonucleotide Therapeutics Product Portfolio
- 7.7.3 Dynavax Technologies Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Kastle therapeutics
- 7.8.1 Kastle therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Kastle therapeutics Oligonucleotide Therapeutics Product Portfolio
- 7.8.3 Kastle therapeutics Oligonucleotide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Oligonucleotide Therapeutics Industry Chain Analysis
- 8.2 Oligonucleotide Therapeutics Product Downstream Application Analysis
- 8.2.1 Global Oligonucleotide Therapeutics Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Oligonucleotide Therapeutics Revenue and Forecast by Application (2020-2032)
- 8.3 Oligonucleotide Therapeutics Typical Downstream Customers
- 8.4 Oligonucleotide Therapeutics Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
